The drug manufacturer Biofarm registered a net profit of 69.9 million RON in the first nine months of the year, up 6% compared to the same period last year, according to a company statement.The turnover increased by 10%, reaching 229 million RON, compared to 209 million RON in 2022. EBITDa reached 81.6 million RON during the mentioned period.In the first nine months of 2023, Biofarm occupied the 2nd place in the CHC (Consumer Healthcare) segment, in terms of the number of units sold. In terms of value, the company consolidated its sales to the final consumer, recording an increase of over 15% compared to the first nine months of 2022, compared to the purchase price in pharmacies.according to the source, the therapeutic areas with the greatest absolute increase in value in the first nine months of the year, in which Biofarm is active, were cold & flu, pain, magnesium-based supplements, digestion and nasal decongestants. The Biofarm brands associated with these therapeutic areas registered increases in their stock market share."The continuous development of new products, constantly adapted to the constantly diversifying consumer needs, represents one of the growth pillars of the Biofarm company. The company is also the volume market leader in the reference categories of eight of its brands: Bixtonim, Colebil, Triferment, Sennalax, Extravalerianic, Carmol solution, Carbocit and Nervocalmin. This balanced mix between long-lived brands and innovation is a strong differentiator for the Biofarm portfolio, positioning the company among the most relevant players in the CHC category," the release states.Biofarm is one of the first Romanian producers of medicines and food supplements, with a tradition of over 100 years. Currently, Biofarm is one of the top 10 existing producers on the pharmaceutical market in Romania and has a product portfolio that covers 65 therapeutic areas.
The demand for logistics and industrial spaces reached 575,000 sqm during the first 9 months of this year, a decrease of 20% compared with the same period of 2023, according to a report by real estate consulting company Cushman & Wakefield Echinox. The figures for Q3 2024 reveal that 164,000 square meters were contracted, a […]
Dutch classical music star André Rieu will return to Romania for two concerts at BTarena in Cluj-Napoca on November 13 and 14, 2025. Rieu’s concerts in Romania, where he enjoys a high degree of popularity, have set multiple attendance records. In 2015 and 2016, he performed nine sold-out shows in Bucharest’s Constitution Square for over […]
Till Lindemann, the frontman of famous German rock band Rammstein, will embark on his "Meine Welt" tour across European arenas in the fall of 2025. Among his stops he is scheduled to perform in Romania on December 4, 2025, at Romexpo in Bucharest, as announced on his official website. The "Meine Welt" tour will take […]
HR Summit, one of the most important events dedicated to the human resources industry in Transylvania, will take place under the theme Shifting Priorities: Talent, Technology, and Trust, on Friday, November 22, at Radisson Blu Hotel in Cluj-Napoca. This year's edition of HR Summit focuses on leadership, employee well-being, the introduction of innovative...
Fourteen Central and Eastern European startups (CEE) have been selected for the first edition of the Impact Creators accelerator, Impact Hub Bucharest and PurposeTech announced. The application period attracted 133 proposals from 18 countries. The startups will participate in an intensive program to accelerate their businesses, which will end with a Pitch Day. The most […]
The immersive art museum MINA Cluj will host a special event featuring Dumitru Prunariu, the only Romanian who flew in space. Scheduled for November 24, the event will give the public the opportunity to hear the stories directly from the one who represented Romania in the Soyuz 40 mission in 1981, carried out as part […]
